Omron Corp. (OTCMKTS:OMRNY) Sees Significant Decrease in Short Interest

Omron Corp. (OTCMKTS:OMRNY) was the target of a large decline in short interest during the month of February. As of February 13th, there was short interest totaling 12,759 shares, a decline of 20.9% from the January 29th total of 16,138 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 161,213 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily trading volume, of 161,213 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s stock are sold short.

Hedge Funds Weigh In On Omron

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC increased its holdings in shares of Omron Corp. (OTCMKTS:OMRNY) by 50.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 at the end of the most recent reporting period. 1.09% of the stock is currently owned by institutional investors.

Omron Stock Performance

OMRNY opened at $35.32 on Monday. Omron has a 52-week low of $23.23 and a 52-week high of $35.90. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.37 and a current ratio of 2.11. The stock has a 50-day moving average of $27.71 and a 200-day moving average of $27.07. The company has a market cap of $7.28 billion, a PE ratio of 44.71, a price-to-earnings-growth ratio of 0.55 and a beta of 0.91.

Omron (OTCMKTS:OMRNY) last released its quarterly earnings results on Thursday, February 5th. The company reported $0.17 EPS for the quarter, missing analysts’ consensus estimates of $0.36 by ($0.19). The firm had revenue of $1.41 billion during the quarter, compared to the consensus estimate of $1.38 billion. Omron had a net margin of 2.80% and a return on equity of 2.46%. Omron has set its FY 2025 guidance at 0.960-0.960 EPS. As a group, equities research analysts forecast that Omron will post 0.42 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.